top of page
A WORKABLE BRAND SYSTEM THAT IS SUSTAINABLE, EASILY MANAGED AND MAINTAINED.
Testing during a pandemic.
Tracking the virus is as important as testing for it.
Strategy
Design
​
Quidel Corporation was granted Emergency Use Authorization (EUA) for its Sofia SARS Antigen Fluorescent Immunoassay (FIA). The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.
Brook-Schwartz+ suggested a series of ads focusing on testing for Covid-19, not only for Covid-19 testing, but the devices ability for wireless surveillance testing and reporting.
bottom of page